Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Characterization of Retinal Exudates in Coats Disease - lipid profile (Study ST000669)

C18 POSITIVE ION MODE (Analysis AN001025)

Metabolite	Structure	F1	F2	F3	F4
lysoPC 22:5; [M+H]+@1.60	ME183578	3.24	0.11	0.20	1.24
lysoPC 18:2; [M+H]+@1.42	ME183565	3.37	0.00	0.07	1.49
lysoPC 18:2; [M+Na]+@1.28	ME183566	3.36	0.01	0.06	1.51
lysoPE 18:2; [M+H]+@1.32	ME183587	3.19	0.03	0.13	1.51
lysoPC 22:6; [M+H]+@1.28	ME183579	3.08	0.07	0.17	1.52
lysoPC 20:3; [M+H]+@1.64	ME183571	3.00	0.03	0.17	1.62
lysoPC 20:4; [M+H]+@1.43	ME183572	3.08	0.04	0.13	1.61
lysoPC 20:5; [M+H]+@1.11	ME183573	2.83	0.01	0.01	1.15
lysoPC 18:1; [M+H]+@1.84	ME183563	2.66	0.02	0.58	1.16
lysoPC 16:1; [M+H]+@1.28	ME183558	2.69	0.04	0.49	1.29
lysoPC 18:1; [M+Na]+@1.86	ME183564	2.81	0.02	0.46	1.25
plasmenyl-PC 18:0; [M+Na]+@1.87	ME183591	2.81	0.02	0.46	1.25
lysoPE 22:5; [M+H]+@1.63	ME183589	2.45	NA	0.09	1.37
lysoPE 20:4; [M+H]+@1.35	ME183588	2.67	0.20	0.31	1.51
lysoPE 22:6; [M+H]+@1.29	ME183590	2.65	0.15	0.26	1.69
lysoPC 15:0; [M+Na]+@1.57	ME183555	2.80	0.21	0.67	0.65
PC 36:2; [M+Na]+@9.57	ME183343	2.52	0.32	0.15	NA
SM 38:1; [M]+@8.44	ME183399	1.16	0.84	NA	NA
PC 38:3; [M+H]+@8.69	ME183355	1.67	NA	0.33	NA
PC 38:6; [M+H]+@8.09	ME183358	1.68	NA	0.32	NA
PE 36:3; [M+Na]+@6.29	ME183374	0.72	1.25	0.85	1.33
PE 38:6; [M+H]+@6.29	ME183378	0.75	1.27	0.80	1.38
IS d5-DAG	ME183316	0.98	1.33	0.76	1.18
TG 52:2; [M+Na]+@10.62	ME183465	0.99	1.32	0.86	0.96
TG 54:3; [M+Na]+@10.66	ME183486	1.10	0.95	0.87	1.21
MG 17:0; [M+Li]+@3.18	ME183318	0.99	1.05	0.92	1.12
IS lysoPC 17:0;[M+H]+	ME183317	1.08	1.07	0.92	1.01
IS MG 17:0; [M+NH4]+	ME183310	1.03	1.02	0.98	1.00
IS SM 35:1;[M+H]+	ME183314	0.95	1.01	1.02	1.00
PE 38:4; [M+H]+@7.04	ME183376	0.47	1.23	1.32	0.67
SM 36:1; [M+Na]+@6.75	ME183395	0.25	1.30	1.34	0.76
DG 36:0; [M+NH4]+@8.86	ME183290	0.59	1.08	1.25	0.83
TG 48:1; [M+Na]+@10.35	ME183439	0.72	1.20	1.14	0.80
PE 36:4; [M+H]+@6.40	ME183375	0.70	1.21	1.24	0.60
PE 38:5; [M+H]+@6.57	ME183377	0.82	1.01	1.28	0.61
TG 52:1; [M+Na]+@10.81	ME183463	0.34	1.46	1.05	1.09
IS PE 34:0; [M+H]+	ME183312	0.64	1.75	0.95	0.71
PE 34:0; [M+H]+@7.39	ME183368	0.65	1.74	0.96	0.70
IS PC 34:0; [M+H]+	ME183311	0.73	1.47	0.99	0.82
TG 53:0; [M+NH4]+@11.15	ME183475	0.88	1.59	0.94	0.65
SM 35:1; [M+Na]+@6.37	ME183392	0.16	3.23	0.74	0.13
IS CE 17:0; [M+NH4]+	ME183306	0.88	2.21	0.48	0.94
IS D31-TAG	ME183308	0.91	2.63	0.41	0.64
IS TG 51:0; [M+NH4]+	ME183315	0.67	2.67	0.49	0.68
DG 38:4; [M+NH4]+@7.95	ME183298	0.12	1.94	1.32	0.30
IS Ceramide;[M-H20]+	ME183307	0.46	1.97	0.97	0.63
PE 40:6; [M+H]+@6.97	ME183379	0.46	2.28	0.89	0.49
PC 35:5; [M+H]+@5.63	ME183340	NA	0.47	1.26	NA
PC 36:5; [M+H]+@6.54	ME183349	NA	1.02	0.99	NA
PC 36:4; [M+H]+@5.21	ME183345	NA	0.77	1.12	NA
PC 33:2; [M+Na]+@6.21	ME183329	NA	0.90	1.05	NA
PC 34:2; [M+Na]+@6.47	ME183334	NA	0.88	1.06	NA
DG 40:7; [M+NH4]+@7.55	ME183303	0.16	0.50	1.76	0.82
PC 32:1; [M+Na]+@6.33	ME183326	NA	0.66	1.49	0.36
TG 66:12; [M+NH4]+@10.49	ME183552	NA	0.41	1.56	0.46
DG 32:0; [M+NH4]+@7.93	ME183283	0.35	0.66	1.89	0.22
DG 40:5; [M+NH4]+@8.03	ME183301	0.37	0.98	1.80	0.05
plasmenyl-PE 40:4; [M+H]+@7.74	ME183603	0.68	0.81	1.50	0.51
TG 40:0; [M+Na]+@9.48	ME183425	0.50	0.95	1.44	0.67
DG 38:3; [M+NH4]+@8.20	ME183297	0.24	1.04	1.63	0.45
DG 40:6; [M+NH4]+@7.71	ME183302	0.20	0.96	1.70	0.44
DG 34:0; [M+NH4]+@8.42	ME183286	0.39	0.79	1.66	0.50
plasmenyl-PE 40:5; [M+H]+@7.31	ME183604	0.48	0.89	1.60	0.43
TG 59:2; [M+NH4]+@11.44	ME183526	1.23	0.05	1.85	0.02
CE(20:4); [M+NH4]+@11.35	ME183278	0.90	0.08	1.51	NA
SM 30:0; [M]+@4.74	ME183380	0.82	0.21	1.91	0.14
TG 59:7; [M+NH4]+@10.56	ME183528	0.54	0.01	1.72	NA
PC 36:0; [M+H]+@8.60	ME183341	1.60	0.74	1.25	0.16
DG 35:2; [M+NH4]+@7.96	ME183289	1.05	0.53	1.59	0.25
TG 53:2; [M+NH4]+@10.74	ME183477	1.27	0.29	1.22	NA
DG 32:2; [M+NH4]+@7.04	ME183285	0.84	0.30	1.70	0.46
MG 18:0; [M+Li]+@3.64	ME183319	0.86	0.44	1.51	0.68
MG 18:0; [M+NH4]+@3.68	ME183320	0.86	0.44	1.54	0.63
plasmenyl-PE 36:4; [M+H]+@6.71	ME183598	0.74	0.42	1.61	0.61
plasmenyl-PE 38:4; [M+H]+@7.28	ME183601	0.68	0.51	1.62	0.56
TG 50:0; [M+NH4]+@10.81	ME183446	0.67	0.47	1.66	0.53
SM 34:2; [M+Na]+@5.45	ME183390	0.97	0.01	1.73	0.57
lysoPC 20:1; [M+H]+@2.66	ME183570	0.88	0.00	1.81	0.49
SM 35:2; [M]+@5.80	ME183394	0.87	0.11	1.76	0.51
SM 37:2; [M]+@6.63	ME183398	1.03	0.16	1.56	0.68
lysoPE 18:0; [M+H]+@2.49	ME183585	1.04	0.23	1.57	0.59
PC 38:1; [M+H]+@8.47	ME183354	1.03	0.26	1.56	0.60
SM 40:5; [M]+@6.06	ME183407	1.15	0.06	1.50	0.78
CE(22:6); [M+NH4]+@10.49	ME183281	1.01	0.10	1.55	0.79
SM 34:1; [M+Na]+@5.99	ME183388	0.94	0.13	1.54	0.85
TG 56:7; [M+NH4]+@10.19	ME183507	0.72	0.04	1.54	1.16
TG 56:6; [M+NH4]+@10.39	ME183506	0.72	0.05	1.64	0.96
TG 59:3; [M+NH4]+@11.31	ME183527	0.76	0.01	1.62	1.00
DG 36:3; [M+NH4]+@7.75	ME183293	0.78	0.14	1.54	0.99
TG 50:1; [M+NH4]+@10.61	ME183447	0.72	0.20	1.51	1.05
PC 42:5; [M+H]+@7.80	ME183366	0.50	0.17	1.71	0.91
TG 58:10; [M+NH4]+@9.96	ME183516	0.37	0.01	1.91	0.79
TG 46:3; [M+NH4]+@9.64	ME183436	0.35	0.09	1.80	0.95
plasmenyl-PC 38:4; [M+Na]+@6.93	ME183592	0.45	0.11	1.83	0.78
TG 51:2; [M+NH4]+@9.85	ME183455	0.38	0.17	1.81	0.84
SM 39:2; [M]+@7.24	ME183403	0.77	0.20	1.63	0.78
DG 36:2; [M+NH4]+@8.09	ME183292	0.71	0.13	1.68	0.80
TG 48:1; [M+NH4]+@10.35	ME183438	0.65	0.18	1.69	0.80
TG 54:2; [M+NH4]+@10.82	ME183483	0.69	0.23	1.65	0.79
CE(20:3); [M+NH4]+@10.84	ME183276	0.82	0.14	1.68	0.69
lysoPC 20:0; [M+H]+@3.49	ME183569	0.74	0.06	1.80	0.60
SM 42:2; [M]+@8.31	ME183415	0.73	0.07	1.75	0.70
SM 37:1; [M]+@7.14	ME183397	0.61	0.21	1.80	0.58
SM 38:2; [M]+@6.87	ME183400	0.58	0.28	1.80	0.54
DG 34:2; [M+NH4]+@7.60	ME183287	0.50	0.30	1.75	0.69
plasmenyl-PE 38:6; [M+H]+@6.61	ME183602	0.57	0.24	1.75	0.70
TG 48:2; [M+NH4]+@10.11	ME183440	0.58	0.12	1.74	0.81
PC 40:2; [M+H]+@8.62	ME183362	0.56	0.16	1.79	0.70
SM 40:4; [M]+@6.47	ME183406	0.56	0.12	1.82	0.68
SM 42:5; [M]+@6.70	ME183418	0.55	0.02	1.85	0.73
TG 48:3; [M+NH4]+@9.87	ME183442	0.57	0.07	1.82	0.72
TG 56:5; [M+NH4]+@10.54	ME183505	0.56	0.07	1.80	0.76
PC 17:0; [M+H]+@1.68	ME183322	0.52	NA	1.86	0.62
SM 33:1; [M+Na]+@5.62	ME183385	0.66	0.02	1.89	0.54
SM 42:1; [M]+@11.10	ME183413	0.61	NA	1.81	0.58
IS PS 34:0;[M+H]+	ME183313	0.57	0.79	1.40	0.85
DG 34:3; [M+NH4]+@7.21	ME183288	0.60	0.61	1.43	0.94
TG 48:2; [M+Na]+@10.14	ME183441	0.63	0.69	1.34	1.00
DG 38:6; [M+NH4]+@7.29	ME183300	0.61	0.51	1.39	1.10
DG 36:4; [M+NH4]+@7.31	ME183294	0.77	0.43	1.40	1.01
DG 38:5; [M+NH4]+@7.62	ME183299	0.78	0.49	1.37	0.99
CE(16:1); [M+NH4]+@10.69	ME183270	0.89	0.32	1.48	0.84
PE 36:3; [M+H]+@6.58	ME183373	0.75	0.47	1.48	0.82
plasmenyl-PE 40:6; [M+H]+@7.25	ME183605	0.65	0.44	1.56	0.79
TG 48:0; [M+NH4]+@10.56	ME183437	0.60	0.32	1.59	0.90
TG 52:1; [M+NH4]+@10.82	ME183462	0.71	0.35	1.50	0.96
SM 42:5; [M]+@7.67	ME183419	1.27	0.58	1.10	0.95
TG 50:2; [M+Na]+@10.38	ME183449	1.30	0.70	0.94	1.11
SM 40:2; [M+Na]+@7.54	ME183405	1.06	0.74	1.13	1.07
SM 41:2; [M+Na]+@7.91	ME183410	0.97	0.70	1.19	0.96
TG 54:2; [M+Na]+@10.85	ME183484	0.89	0.82	1.19	0.91
PE 36:2; [M+H]+@7.04	ME183372	0.93	0.46	1.37	0.87
TG 49:1; [M+NH4]+@10.44	ME183443	1.00	0.52	1.26	0.96
lysoPC 19:0; [M+H]+@3.01	ME183568	1.15	0.59	1.21	0.84
plasmenyl-PE 36:5; [M+H]+@6.32	ME183599	1.15	0.47	1.32	0.75
SM 31:1; [M]+@4.83	ME183382	0.52	NA	1.59	0.30
CE(20:5); [M+NH4]+@9.24	ME183280	0.48	NA	1.50	0.52
SM 33:2; [M]+@5.14	ME183386	0.45	NA	1.50	0.54
TG 55:1; [M+NH4]+@11.18	ME183495	NA	0.11	1.78	0.33
TG 57:4; [M+NH4]+@10.82	ME183513	NA	NA	1.57	0.43
lysoPC 23:0; [M+H]+@4.96	ME183580	0.13	NA	1.74	0.39
TG 54:0; [M+NH4]+@11.29	ME183481	0.27	NA	1.64	0.44
TG 60:13; [M+NH4]+@9.73	ME183533	0.15	NA	1.47	0.90
TG 51:1; [M+NH4]+@10.12	ME183454	NA	NA	1.25	0.51
TG 56:0; [M+NH4]+@11.32	ME183499	NA	NA	1.28	0.45
TG 57:1; [M+NH4]+@11.43	ME183512	0.04	NA	1.48	NA
DG 42:5; [M+NH4]+@7.62	ME183305	NA	0.00	1.50	NA
TG 64:12; [M+NH4]+@10.26	ME183549	NA	0.02	1.49	NA
TG 55:2; [M+NH4]+@11.05	ME183496	NA	0.02	1.98	NA
TG 60:6; [M+NH4]+@10.81	ME183538	0.07	0.04	1.95	NA
TG 58:5; [M+NH4]+@10.78	ME183522	NA	0.04	1.90	0.17
TG 60:5; [M+NH4]+@11.06	ME183537	0.08	NA	1.90	0.11
TG 62:6; [M+NH4]+@11.03	ME183546	0.03	NA	1.94	0.10
TG 53:1; [M+NH4]+@10.96	ME183476	0.08	0.33	1.80	NA
lysoPC 16:0; [M+H]+@3.18	ME183557	NA	0.16	1.84	NA
lysoPC 18:0; [M+H]+@2.47	ME183561	NA	0.18	1.82	NA
TG 62:7; [M+NH4]+@10.84	ME183547	0.00	0.30	2.27	0.15
PC 32:0; [M+H]+@5.63	ME183325	0.23	NA	2.52	0.25
TG 64:7; [M+NH4]+@11.06	ME183550	0.07	0.08	2.42	0.01
CE(24:1); [M+NH4]+@12.00	ME183282	0.05	0.05	2.43	0.04
TG 62:9; [M+NH4]+@10.55	ME183548	0.02	0.06	2.45	0.03
lysoPC 24:1; [M+H]+@4.50	ME183582	0.05	0.12	2.36	0.12
TG 64:8; [M+NH4]+@11.00	ME183551	0.06	0.12	2.36	0.11
TG 62:14; [M+NH4]+@9.83	ME183542	0.02	0.00	2.43	0.13
TG 60:4; [M+NH4]+@11.14	ME183536	0.08	0.04	2.35	0.18
TG 60:9; [M+NH4]+@10.31	ME183539	0.08	0.04	2.34	0.19
TG 62:5; [M+NH4]+@11.18	ME183545	0.05	0.02	2.39	0.16
TG 62:11; [M+NH4]+@10.24	ME183540	0.04	0.02	2.38	0.19
TG 62:12; [M+NH4]+@10.11	ME183541	0.02	0.03	2.38	0.19
SM 35:0; [M]+@9.18	ME183391	0.06	0.02	2.30	0.33
CE(18:3); [M+NH4]+@9.24	ME183274	0.29	0.03	2.24	0.20
lysoPC 18:0; [M+H]+@3.09	ME183560	0.25	0.01	2.28	0.18
TG 62:3; [M+NH4]+@11.63	ME183544	0.23	0.03	2.30	0.13
TG 62:2; [M+NH4]+@11.88	ME183543	0.13	0.01	2.31	0.23
TG 60:10; [M+NH4]+@10.21	ME183530	0.17	0.04	2.30	0.20
TG 60:3; [M+NH4]+@11.40	ME183535	0.16	0.02	2.31	0.20
TG 60:11; [M+NH4]+@10.05	ME183531	0.16	0.01	2.27	0.29
TG 60:2; [M+NH4]+@11.59	ME183534	0.11	0.05	2.29	0.26
SM 37:0; [M]+@9.62	ME183396	0.16	0.10	2.31	0.11
PC 32:0; [M+H]+@6.84	ME183324	0.19	0.10	2.27	0.17
TG 58:4; [M+NH4]+@10.98	ME183521	0.20	0.08	2.25	0.21
TG 60:1; [M+NH4]+@11.83	ME183529	0.18	0.10	2.26	0.20
PE 34:1; [M+H]+@6.87	ME183369	0.61	0.43	1.84	0.28
TG 44:1; [M+Na]+@9.82	ME183431	0.23	0.31	2.01	0.43
DG 36:1; [M+NH4]+@8.47	ME183291	0.44	0.20	2.00	0.35
DG 32:1; [M+NH4]+@7.46	ME183284	0.48	0.37	1.87	0.42
DG 40:8; [M+NH4]+@7.20	ME183304	0.43	0.41	1.91	0.34
TG 46:0; [M+NH4]+@10.32	ME183433	0.34	0.29	1.93	0.51
plasmenyl-PE 34:1; [M+H]+@7.24	ME183594	0.44	0.29	1.93	0.42
TG 54:1; [M+NH4]+@11.11	ME183482	0.48	0.24	1.90	0.49
SM 35:1; [M]+@9.47	ME183393	0.26	0.47	1.85	0.57
IS DG 34:1; [M+NH4]+	ME183309	0.53	0.44	1.77	0.49
MG 18:1; [M+NH4]+@2.93	ME183321	0.46	0.58	1.79	0.38
TG 40:0; [M+NH4]+@9.49	ME183424	0.33	0.51	1.88	0.40
TG 52:0; [M+NH4]+@11.10	ME183461	0.39	0.51	1.84	0.42
lysoPC 22:2; [M+H]+@2.88	ME183576	0.31	0.32	2.11	0.15
SM 32:1; [M+Na]+@5.23	ME183383	0.64	0.00	1.98	0.40
SM 30:1; [M]+@4.41	ME183381	0.54	0.03	2.03	0.38
SM 32:1; [M]+@5.08	ME183384	0.54	0.02	1.99	0.46
SM 34:1; [M]+@5.93	ME183389	0.53	0.03	2.00	0.44
TG 56:4; [M+NH4]+@10.80	ME183504	0.35	0.13	1.93	0.66
SM 42:4; [M]+@7.07	ME183417	0.46	0.04	1.97	0.55
SM 44:2; [M]+@8.69	ME183423	0.45	0.06	1.97	0.55
DG 38:2; [M+NH4]+@8.51	ME183296	0.40	0.12	1.97	0.55
TG 56:3; [M+NH4]+@11.00	ME183503	0.45	0.14	1.94	0.54
TG 40:1; [M+NH4]+@9.18	ME183426	0.09	0.18	2.18	0.38
TG 42:0; [M+NH4]+@9.77	ME183427	0.14	0.22	2.15	0.34
TG 46:1; [M+NH4]+@10.08	ME183434	0.23	0.19	2.14	0.30
TG 42:1; [M+NH4]+@9.55	ME183428	0.17	0.14	2.16	0.38
TG 44:1; [M+NH4]+@9.82	ME183430	0.19	0.12	2.16	0.36
TG 58:2; [M+NH4]+@11.32	ME183519	0.19	0.07	2.20	0.34
TG 58:3; [M+NH4]+@11.12	ME183520	0.22	0.08	2.17	0.36
TG 58:7; [M+NH4]+@10.41	ME183523	0.22	0.05	2.17	0.39
TG 46:2; [M+NH4]+@9.82	ME183435	0.31	0.13	2.08	0.40
TG 58:8; [M+NH4]+@10.34	ME183524	0.28	0.02	2.14	0.43
TG 58:1; [M+NH4]+@11.55	ME183515	0.27	0.07	2.10	0.47
SM 34:0; [M]+@6.30	ME183387	0.32	0.05	2.08	0.47
TG 56:2; [M+NH4]+@11.09	ME183502	0.32	0.08	2.07	0.45
TG 42:2; [M+NH4]+@9.22	ME183429	0.22	0.04	2.08	0.58
TG 58:9; [M+NH4]+@10.14	ME183525	0.28	0.01	2.08	0.54
TG 44:2; [M+NH4]+@9.58	ME183432	0.19	0.08	2.12	0.50
TG 60:12; [M+NH4]+@9.88	ME183532	0.15	0.03	2.18	0.47
lysoPC 22:1; [M+H]+@3.58	ME183575	0.63	0.04	2.06	0.20
CE(20:1); [M+NH4]+@11.28	ME183275	0.36	0.08	2.14	0.28
lysoPC 22:0; [M+H]+@4.46	ME183574	0.38	0.03	2.12	0.35
TG 56:1; [M+NH4]+@11.30	ME183500	0.39	0.07	2.08	0.37
lysoPC 24:0; [M+H]+@5.40	ME183581	0.45	0.02	2.15	0.22
lysoPC 26:1; [M+H]+@5.68	ME183583	0.44	0.11	2.15	0.14
PC 36:4; [M+H]+@8.74	ME183347	NA	NA	0.26	1.74
plasmenyl-PE 38:2; [M+H]+@8.01	ME183600	NA	NA	0.97	1.06
lysoPC 22:4; [M+H]+@1.87	ME183577	1.93	0.09	1.09	0.80
lysoPC 18:0; [M+Na]+@2.28	ME183562	1.58	0.00	1.21	1.00
PC 21:4; [M+H]+@1.49	ME183323	1.47	0.10	1.29	0.86
CE(20:4); [M+NH4]+@10.60	ME183277	1.32	0.18	1.22	1.06
TG 51:3; [M+NH4]+@10.32	ME183457	1.31	0.09	1.25	1.10
TG 53:3; [M+NH4]+@10.54	ME183478	1.32	0.14	1.19	1.16
SM 43:1; [M]+@8.99	ME183420	1.22	0.02	1.33	1.11
TG 53:5; [M+NH4]+@10.13	ME183480	1.27	0.03	1.26	1.19
CE(20:5); [M+NH4]+@10.37	ME183279	1.33	0.08	1.13	1.33
TG 50:4; [M+NH4]+@9.95	ME183452	1.16	0.04	1.17	1.47
TG 54:5; [M+NH4]+@10.26	ME183488	1.19	0.04	1.19	1.38
TG 52:3; [M+NH4]+@10.40	ME183466	1.14	0.08	1.22	1.34
TG 56:8; [M+Na]+@10.00	ME183510	1.19	0.12	1.18	1.32
SM 38:4; [M]+@5.93	ME183401	1.10	0.20	1.30	1.09
CE(18:1); [M+NH4]+@11.05	ME183272	1.16	0.10	1.34	1.06
TG 49:3; [M+NH4]+@10.05	ME183445	1.17	0.13	1.35	1.00
TG 57:8; [M+NH4]+@10.20	ME183514	1.17	0.14	1.40	0.89
SM 41:1; [M]+@8.30	ME183409	1.10	0.03	1.46	0.96
PC 34:1; [M+H]+@6.90	ME183331	1.04	0.12	1.43	0.99
TG 51:2; [M+NH4]+@10.51	ME183456	1.06	0.18	1.39	0.97
TG 50:3; [M+NH4]+@10.15	ME183450	1.03	0.06	1.35	1.21
TG 54:4; [M+NH4]+@10.47	ME183487	1.04	0.07	1.35	1.19
CE(18:0); [M+NH4]+@11.39	ME183271	1.09	0.02	1.41	1.09
SM 41:2; [M]+@7.88	ME183411	0.97	0.06	1.43	1.11
SM 44:1; [M]+@9.48	ME183422	1.03	0.04	1.40	1.14
SM 43:2; [M]+@8.40	ME183421	0.89	0.04	1.51	1.06
TG 50:2; [M+NH4]+@10.37	ME183448	0.90	0.12	1.47	1.04
TG 54:3; [M+NH4]+@10.66	ME183485	0.93	0.16	1.46	0.99
PC 38:0; [M+H]+@7.10	ME183353	0.83	0.14	1.35	1.33
TG 49:2; [M+NH4]+@10.25	ME183444	0.88	0.20	1.35	1.22
plasmenyl-PE 36:1; [M+H]+@7.82	ME183596	1.01	0.35	1.22	1.20
TG 56:7; [M+Na]+@10.16	ME183508	1.05	0.23	1.21	1.30
SM 42:2; [M+Na]+@8.21	ME183414	1.11	0.13	1.28	1.21
TG 52:2; [M+NH4]+@10.63	ME183464	1.00	0.19	1.30	1.20
PE 36:0; [M+H]+@7.95	ME183371	0.54	NA	1.18	1.09
TG 51:5; [M+NH4]+@9.90	ME183460	0.94	NA	0.94	1.18
TG 50:3; [M+Na]+@10.17	ME183451	1.59	0.68	0.88	0.97
lysoPE 16:0; [M+H]+@1.67	ME183584	1.56	0.37	0.97	1.12
TG 52:3; [M+Na]+@10.42	ME183467	1.51	0.53	0.83	1.29
TG 52:4; [M+Na]+@10.22	ME183469	1.74	0.50	0.76	1.23
PC 37:2; [M+H]+@7.63	ME183351	1.41	0.11	0.97	1.54
PC 38:4; [M+H]+@7.08	ME183356	1.42	0.20	0.91	1.56
SM 41:1; [M+Na]+@8.41	ME183408	1.50	0.03	0.99	1.50
TG 51:4; [M+NH4]+@10.11	ME183459	1.39	0.05	1.04	1.48
CE(16:0); [M+NH4]+@11.05	ME183269	1.52	0.20	1.00	1.28
SM 40:1; [M+Na]+@8.20	ME183404	1.48	0.16	1.03	1.31
SM 42:4; [M]+@8.00	ME183416	1.66	0.16	0.94	1.29
SM 42:1; [M+Na]+@8.82	ME183412	1.63	0.07	0.98	1.34
TG 53:4; [M+NH4]+@10.35	ME183479	1.57	0.04	1.00	1.38
PC 38:6; [M+Na]+@6.31	ME183359	1.26	0.58	0.82	1.52
PC 32:3; [M+H]+@5.39	ME183328	1.11	0.29	1.09	1.43
PE 34:2; [M+H]+@6.45	ME183370	1.00	0.40	1.09	1.42
CE(18:2); [M+NH4]+@10.74	ME183273	1.27	0.27	1.06	1.34
plasmenyl-PE 36:2; [M+H]+@7.39	ME183597	1.34	0.36	1.05	1.20
PC 40:9; [M+H]+@6.24	ME183364	1.02	0.48	0.73	2.03
TG 52:6; [M+NH4]+@9.84	ME183472	1.16	0.03	0.90	2.02
TG 54:7; [M+NH4]+@9.90	ME183491	1.26	0.02	0.82	2.08
TG 52:5; [M+NH4]+@10.03	ME183470	1.26	0.03	0.93	1.84
TG 52:4; [M+NH4]+@10.21	ME183468	1.26	0.05	1.02	1.65
TG 54:6; [M+NH4]+@10.09	ME183489	1.23	0.03	1.01	1.71
TG 54:9; [M+NH4]+@9.55	ME183494	0.53	0.01	1.15	2.17
TG 54:8; [M+NH4]+@9.72	ME183493	0.82	NA	0.71	1.76
TG 52:7; [M+NH4]+@9.64	ME183474	0.71	NA	0.95	1.39
plasmenyl-PC 44:4; [M+Na]+@8.98	ME183593	0.63	NA	0.80	1.57
TG 56:10; [M+NH4]+@9.69	ME183501	0.54	NA	0.89	1.68
TG 58:12; [M+NH4]+@9.64	ME183518	0.36	0.10	1.44	1.66
TG 51:3; [M+NH4]+@9.66	ME183458	0.62	0.18	1.63	1.57
TG 56:8; [M+NH4]+@10.06	ME183509	0.67	0.01	1.45	1.43
TG 55:6; [M+NH4]+@10.24	ME183498	0.56	0.03	1.45	1.51
TG 58:11; [M+NH4]+@9.80	ME183517	0.63	0.03	1.42	1.50
TG 56:9; [M+NH4]+@9.82	ME183511	0.73	0.01	1.20	1.87
TG 55:5; [M+NH4]+@10.48	ME183497	0.69	0.21	1.27	1.56
DG 36:5; [M+NH4]+@6.95	ME183295	0.85	0.15	1.14	1.71
TG 50:5; [M+NH4]+@9.77	ME183453	0.95	0.03	1.22	1.58
PC 40:8; [M+Na]+@5.98	ME183363	1.67	1.22	0.50	1.12
PC 34:2; [M+H]+@5.36	ME183332	2.28	0.84	0.23	1.41
PC 42:10; [M+H]+@5.89	ME183365	1.96	0.61	0.79	0.84
PC 35:4; [M+H]+@5.99	ME183339	1.89	0.68	0.53	1.37
PC 36:4; [M+Na]+@6.43	ME183348	2.15	0.68	0.54	1.09
PC 34:3; [M+Na]+@5.94	ME183335	1.33	NA	0.19	1.48
PC 37:5; [M+H]+@6.24	ME183352	1.48	NA	0.01	1.51
lysoPC 18:3; [M+H]+@1.17	ME183567	1.30	NA	NA	0.70
PC 38:4; [M+H]+@9.64	ME183357	1.45	0.49	NA	1.06
PC 32:2; [M+Na]+@5.85	ME183327	1.49	0.11	0.41	2.58
lysoPC 17:1; [M+H]+@1.51	ME183559	2.33	0.09	0.77	1.05
lysoPE 18:1; [M+H]+@1.86	ME183586	2.36	0.11	0.74	1.04
lysoPC 14:0; [M+H]+@1.11	ME183553	2.01	NA	0.33	1.33
lysoPC 15:0; [M+H]+@1.30	ME183554	2.28	0.06	0.55	1.57
lysoPC 16:0; [M+H]+@1.65	ME183556	2.18	0.01	0.73	1.35
PC 34:5; [M+H]+@5.28	ME183338	1.93	0.31	0.24	1.53
PC 42:9; [M+H]+@6.14	ME183367	1.89	0.41	0.48	1.74
TG 52:6; [M+Na]+@9.78	ME183473	1.50	0.03	0.81	1.84
TG 54:7; [M+Na]+@9.84	ME183492	1.59	0.07	0.66	2.02
PC 34:1; [M+H]+@9.46	ME183330	1.67	0.19	0.79	1.57
PC 36:2; [M+H]+@7.12	ME183342	1.68	0.11	0.78	1.65
TG 54:6; [M+Na]+@10.07	ME183490	1.98	0.17	0.63	1.59
plasmenyl-PE 34:2; [M+H]+@6.80	ME183595	1.79	0.25	0.62	1.72
PC 36:3; [M+H]+@6.63	ME183344	1.87	0.07	0.63	1.80
TG 52:5; [M+Na]+@10.03	ME183471	1.75	0.14	0.62	1.87
SM 39:1; [M]+@8.14	ME183402	1.56	0.09	0.33	2.03
PC 36:6; [M+H]+@5.74	ME183350	1.82	0.00	0.15	2.03
PC 38:7; [M+H]+@6.02	ME183360	1.71	NA	0.11	2.08
PC 34:4; [M+H]+@5.82	ME183336	2.15	0.06	0.25	2.30
PC 34:2; [M+H]+@6.45	ME183333	2.30	0.04	0.36	1.93
PC 34:4; [M+Na]+@5.80	ME183337	2.13	0.19	0.43	1.83
PC 36:4; [M+H]+@6.34	ME183346	2.15	0.09	0.45	1.86

Factors:

F1	Disease:AS-Control-P \| Matrix:Plasma \| Sample type:Plasma
F2	Disease:AS-Control-S \| Matrix:SRF \| Sample type:Fluids and Secretions
F3	Disease:Coats \| Matrix:CB \| Sample type:Fluids and Secretions
F4	Disease:JB-Coats-P \| Matrix:Plasma \| Sample type:Plasma

Data matrix